TrialAntimicrobial agents and chemotherapy2015

Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir.

Simone Susser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.